ClinicalTrials.Veeva

Menu

Impact of Environmental Exposures on Tumor Risk in Subjects at Risk of Hereditary SDHx Paraganglioma (PGL-EXPO-1)

A

Assistance Publique - Hôpitaux de Paris

Status

Unknown

Conditions

Environmental Exposure
Genetic Predisposition
SDH Gene Mutation

Study type

Observational

Funder types

Other

Identifiers

NCT04481152
APHP191007
2020-A00567-32 (Other Identifier)

Details and patient eligibility

About

The main objective of the pilot phase of PGLEXPO will be to assess the faisability and to precise methodology of a case-control study designed for testing the impact of environmental and professional exposures on the tumoral risk in SDHx-mutation carriers

Full description

The main objective of the pilot phase of PGLEXPO will be to assess the faisability and to precise methodology of a case-control study designed for testing the impact of environmental and professional exposures on the tumoral risk in SDHx-mutation carriers.

Patients will be selected from subjects with a mutation in one of the SDHx genes. The cases will have developed a tumor, while the controls will be tumor-free. Controls will be matched to the cases according to sex, age and type of gene affected. Past exposures will be sought through a telephone questionnaire.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Cases: SDHx mutation carriers diagnosed for a SDHx-related tumor
  2. Controls: SDHx mutation carriers with no SDHx-related tumor

Exclusion criteria

Incapacity to exercise free and informed consent for the study

Trial contacts and locations

0

Loading...

Central trial contact

Alexandre BUFFET, MD, PhD; Anne-Paule GIMENEZ-ROQUEPLO, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems